Our mission at Strand is to simplify the complexity of genome sequencing, thus making it accessible to everyone.

We started this journey as a spin off from the Indian Institute of Science in the year 2000. We know that hundreds of thousands of lives can be saved if genome sequencing becomes universal and our ~400 strong team comprising engineers, scientists and clinical personnel works tirelessly towards this goal.

We know that our mission relies on building trust with our customers. Our endeavor to earn this trust is based on scientific and technical rigor, and on careful attention to customer needs. We are proud to have built a global network of happy customers and partners, with focus in India and in the US, but believe that we can touch many more people with our efforts in the years to come.

We are grateful that Reliance, India’s most prominent corporate group, is now supporting our mission as our strategic investor.